Literature DB >> 18650777

Role of T cells for cytokine production and outcome in a model of acute septic peritonitis.

Daniel Reim1, Kay Westenfelder, Simone Kaiser-Moore, Sylvia Schlautkötter, Bernhard Holzmann, Heike Weighardt.   

Abstract

Although it is generally accepted that early defense mechanisms are controlled by cells of the innate immune system, T cells were found to be crucial for host resistance against acute septic peritonitis. However, the mechanisms by which T cells mediate protection are not fully understood. Here, we demonstrate mice deficient for recombinase-activating gene (RAG) 1, which lack mature B and T cells, showed enhanced susceptibility and impaired bacterial clearance in a model of acute septic peritonitis. Whereas B-cell-deficient muMT mice showed no significant difference in the survival rate after peritonitis induction, T-cell-deficient Balb/c nude mice exhibited reduced survival. Importantly, analysis of cytokine production in both RAG-1-deficient and T-cell-deficient nude mice indicated strongly attenuated production of IL-12, interferon (IFN) gamma, and IL-10 during sepsis. Reduced cytokine levels were detected both in serum and in organ extracts of septic mice. Direct analysis of T cells isolated from septic mice demonstrated that T cells respond to an acute septic challenge by increased production of IFN-gamma and IL-10. Moreover, bacterial numbers in spleens of septic RAG-1-deficient mice were significantly increased as compared with controls, suggesting that T cells are engaged in the early antibacterial immune defense during sepsis, possibly via the production of IFN-gamma. In summary, these results imply that T cells contribute to protective immune responses against acute systemic infections via their ability to produce crucial immune mediators.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18650777     DOI: 10.1097/SHK.0b013e31817fd02c

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  7 in total

1.  The outcome of polymicrobial sepsis is independent of T and B cells.

Authors:  Markus Bosmann; Norman F Russkamp; Vinay R Patel; Firas S Zetoune; J Vidya Sarma; Peter A Ward
Journal:  Shock       Date:  2011-10       Impact factor: 3.454

2.  Genetic deletion of the HIF-1α isoform I.1 in T cells enhances antibacterial immunity and improves survival in a murine peritonitis model.

Authors:  Peter Georgiev; Bryan G Belikoff; Stephen Hatfield; Akio Ohta; Michail V Sitkovsky; Dmitriy Lukashev
Journal:  Eur J Immunol       Date:  2013-01-31       Impact factor: 5.532

3.  The role of CXCL10 in the pathogenesis of experimental septic shock.

Authors:  Daniela S Herzig; Liming Luan; Julia K Bohannon; Tracy E Toliver-Kinsky; Yin Guo; Edward R Sherwood
Journal:  Crit Care       Date:  2014-06-02       Impact factor: 9.097

4.  Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naïve T-cells but no enduring cell-autonomous defects in T-cell function.

Authors:  Robby Markwart; Stephanie A Condotta; Robert P Requardt; Farina Borken; Katja Schubert; Cynthia Weigel; Michael Bauer; Thomas S Griffith; Martin Förster; Frank M Brunkhorst; Vladimir P Badovinac; Ignacio Rubio
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

5.  WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs.

Authors:  Ulrich Matt; Omar Sharif; Rui Martins; Tanja Furtner; Lorene Langeberg; Riem Gawish; Immanuel Elbau; Ana Zivkovic; Karin Lakovits; Olga Oskolkova; Bianca Doninger; Andreas Vychytil; Thomas Perkmann; Gernot Schabbauer; Christoph J Binder; Valery N Bochkov; John D Scott; Sylvia Knapp
Journal:  J Clin Invest       Date:  2013-06-24       Impact factor: 14.808

6.  Foxp3+ regulatory T cells are required for recovery from severe sepsis.

Authors:  Franziska Kühlhorn; Matthias Rath; Katrin Schmoeckel; Katharina Cziupka; Huu Hung Nguyen; Petra Hildebrandt; Thomas Hünig; Tim Sparwasser; Jochen Huehn; Christian Pötschke; Barbara M Bröker
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

Review 7.  Is boosting the immune system in sepsis appropriate?

Authors:  Jean-Marc Cavaillon; Damon Eisen; Djilalli Annane
Journal:  Crit Care       Date:  2014-03-24       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.